by Ayaskant Pany, MD, Sorika van Niekerk, MSc, UP, SA, Stephen Mortlock, DSc., and Wayne R. Hogrefe, Ph.D., D (ABMLI)
This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola. At Q2 Solutions, we support infectious disease clinical trials with a variety of tools including:
Download this white paper and learn how we are applying the latest technologies to provide insights for better management of infectious disease clinical trials. New diagnostics and therapies developed as a result can then be used against target pathogens and their resistant variants for improved safety.